A5028356612- Glycosylation and Glycoproteins Research
- Cancer Genomics and Diagnostics
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Hepatitis B Virus Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Immunotherapy and Immune Responses
- Cancer Mechanisms and Therapy
- Lung Cancer Treatments and Mutations
Qingdao University
2019-2021
Affiliated Hospital of Qingdao University
2019-2021
Hepatocellular carcinoma (HCC) is one of the most common causes cancer worldwide. Although many studies have focused on oncogene characteristics, genomic landscape Chinese HCC patients has not been fully clarified.A total 165 patients, including 146 males and 19 females, were enrolled. The median age was 55 years (range, 27-78 years). Corresponding clinical pathological information collected for further analysis. A 168 tumor tissues from these selected next-generation sequencing (NGS)-based...
Aim . Little is known about the association between cancer antigen 125 (MUC16/CA125) concentrations and tumor diameter of patients with hepatocellular carcinoma (HCC) low AFP levels. To fill this gap in our knowledge, we conducted a retrospective study 427 HCC ≤200 ng/mL who underwent R0 resection at center. Methods The associations CA125 patients’ clinicopathological characteristics were analyzed. Survival vs levels was also evaluated patient groups ≤30 U/mL or >30 U/mL. Independent risk...
Objective To investigate the prognostic value of preoperative serum level cancer antigen (CA) 125 in hepatocellular carcinoma (HCC) patients with a low AFP after R0 resection. Methods Clinical data 427 HCC who underwent resection Affiliated Hospital Qingdao University from January 2009 to December 2015 were retrospectively analyzed. Among them, 366 male and 61 female, aged (57±10) years on average, AFP≤200 μg/L. The informed consents all obtained local ethical committee approval was...